ArticleEClinicalMedicine2023

Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancer.

Celestia S Higano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.